Cargando…

GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia

BACKGROUND: Although the conventional, monopolar transurethral resection of the prostate (TURP) has proven to be an effective and relatively safe treatment for patients with benign prostatic hyperplasia (BPH), many new endoscopic technologies have been introduced to treat BPH. With the development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Xiangming, Qiu, Zikai, Dong, Jie, Liu, Guanghua, Xie, Yi, Xu, Weifeng, Ji, Zhigang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215003/
https://www.ncbi.nlm.nih.gov/pubmed/32420160
http://dx.doi.org/10.21037/tau.2020.02.04
_version_ 1783532091340750848
author Cheng, Xiangming
Qiu, Zikai
Dong, Jie
Liu, Guanghua
Xie, Yi
Xu, Weifeng
Ji, Zhigang
author_facet Cheng, Xiangming
Qiu, Zikai
Dong, Jie
Liu, Guanghua
Xie, Yi
Xu, Weifeng
Ji, Zhigang
author_sort Cheng, Xiangming
collection PubMed
description BACKGROUND: Although the conventional, monopolar transurethral resection of the prostate (TURP) has proven to be an effective and relatively safe treatment for patients with benign prostatic hyperplasia (BPH), many new endoscopic technologies have been introduced to treat BPH. With the development of laser, there are several alternative transurethral procedures embracing laser therapies. Herein, this study sought to explore the efficacy, safety and follow-up of GreenLight laser photoselective vapo-enucleation of the prostate (PVEP) with front-firing emission compared with plasmakinetic resection of the prostate (PKRP) used to surgically manage BPH. METHODS: Data from patients who underwent either GreenLight laser PVEP or PKRP were retrospectively collected from March 2013 to May 2018. Perioperative data from both groups were compared. RESULTS: Totally, 43 and 45 patients were included in the PVEP and PKRP groups, respectively. No significant difference was observed in excision efficiency ratio (resected prostate weight/operation time) between the two groups (P=0.372). The efficiency ratio of the first 20 PVEP procedures (0.36±0.09 g/min) was significantly lower than that of the second 23 PVEP procedures (0.45±0.18 g/min) (P=0.042). The PVEP group experienced a shorter duration of catheterization, postoperative hospital stay and irrigation time than the PKRP group (P<0.001, P=0.001 and P<0.001, respectively). There was no statistically significant difference between the two groups (P=0.937) in terms of overall postoperative complications. Three months after surgery, the international prostate symptoms (IPSS) score, quality of life (QOL) score, postvoid residual (PVR) volume and maximum urinary flow rate (Q(max)) were decreased in both groups (P<0.001 for all) and were comparable between both groups (P=0.635, 0.662, 0.671 and 0.924, respectively). CONCLUSIONS: GreenLight laser PVEP with front-firing emission was safe and effective modality in treating patients with BPH with short-term follow-up. PVEP was associated with shorter catheterization and postoperative hospital stay time compared with PKRP.
format Online
Article
Text
id pubmed-7215003
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-72150032020-05-15 GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia Cheng, Xiangming Qiu, Zikai Dong, Jie Liu, Guanghua Xie, Yi Xu, Weifeng Ji, Zhigang Transl Androl Urol Original Article BACKGROUND: Although the conventional, monopolar transurethral resection of the prostate (TURP) has proven to be an effective and relatively safe treatment for patients with benign prostatic hyperplasia (BPH), many new endoscopic technologies have been introduced to treat BPH. With the development of laser, there are several alternative transurethral procedures embracing laser therapies. Herein, this study sought to explore the efficacy, safety and follow-up of GreenLight laser photoselective vapo-enucleation of the prostate (PVEP) with front-firing emission compared with plasmakinetic resection of the prostate (PKRP) used to surgically manage BPH. METHODS: Data from patients who underwent either GreenLight laser PVEP or PKRP were retrospectively collected from March 2013 to May 2018. Perioperative data from both groups were compared. RESULTS: Totally, 43 and 45 patients were included in the PVEP and PKRP groups, respectively. No significant difference was observed in excision efficiency ratio (resected prostate weight/operation time) between the two groups (P=0.372). The efficiency ratio of the first 20 PVEP procedures (0.36±0.09 g/min) was significantly lower than that of the second 23 PVEP procedures (0.45±0.18 g/min) (P=0.042). The PVEP group experienced a shorter duration of catheterization, postoperative hospital stay and irrigation time than the PKRP group (P<0.001, P=0.001 and P<0.001, respectively). There was no statistically significant difference between the two groups (P=0.937) in terms of overall postoperative complications. Three months after surgery, the international prostate symptoms (IPSS) score, quality of life (QOL) score, postvoid residual (PVR) volume and maximum urinary flow rate (Q(max)) were decreased in both groups (P<0.001 for all) and were comparable between both groups (P=0.635, 0.662, 0.671 and 0.924, respectively). CONCLUSIONS: GreenLight laser PVEP with front-firing emission was safe and effective modality in treating patients with BPH with short-term follow-up. PVEP was associated with shorter catheterization and postoperative hospital stay time compared with PKRP. AME Publishing Company 2020-04 /pmc/articles/PMC7215003/ /pubmed/32420160 http://dx.doi.org/10.21037/tau.2020.02.04 Text en 2020 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Cheng, Xiangming
Qiu, Zikai
Dong, Jie
Liu, Guanghua
Xie, Yi
Xu, Weifeng
Ji, Zhigang
GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia
title GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia
title_full GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia
title_fullStr GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia
title_full_unstemmed GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia
title_short GreenLight Laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia
title_sort greenlight laser photoselective vapo-enucleation of the prostate with front-firing emission versus plasmakinetic resection of the prostate for benign prostate hyperplasia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215003/
https://www.ncbi.nlm.nih.gov/pubmed/32420160
http://dx.doi.org/10.21037/tau.2020.02.04
work_keys_str_mv AT chengxiangming greenlightlaserphotoselectivevapoenucleationoftheprostatewithfrontfiringemissionversusplasmakineticresectionoftheprostateforbenignprostatehyperplasia
AT qiuzikai greenlightlaserphotoselectivevapoenucleationoftheprostatewithfrontfiringemissionversusplasmakineticresectionoftheprostateforbenignprostatehyperplasia
AT dongjie greenlightlaserphotoselectivevapoenucleationoftheprostatewithfrontfiringemissionversusplasmakineticresectionoftheprostateforbenignprostatehyperplasia
AT liuguanghua greenlightlaserphotoselectivevapoenucleationoftheprostatewithfrontfiringemissionversusplasmakineticresectionoftheprostateforbenignprostatehyperplasia
AT xieyi greenlightlaserphotoselectivevapoenucleationoftheprostatewithfrontfiringemissionversusplasmakineticresectionoftheprostateforbenignprostatehyperplasia
AT xuweifeng greenlightlaserphotoselectivevapoenucleationoftheprostatewithfrontfiringemissionversusplasmakineticresectionoftheprostateforbenignprostatehyperplasia
AT jizhigang greenlightlaserphotoselectivevapoenucleationoftheprostatewithfrontfiringemissionversusplasmakineticresectionoftheprostateforbenignprostatehyperplasia